Cancer of Unknown Primary (Record no. 6777)

MARC details
000 -LEADER
fixed length control field 03838nam a22002897a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192439.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220531b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 3319225812
International Standard Book Number 9783319225814
040 ## - CATALOGING SOURCE
Transcribing agency dlc
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Alwin Krämer
9 (RLIN) 38267
245 ## - TITLE STATEMENT
Title Cancer of Unknown Primary
250 ## - EDITION STATEMENT
Edition statement illustrated
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Clinical Cooperation Unit Molecular Hematology/Oncology German Cancer Research Center (DKFZ) and University of Heidelberg Heidelberg Germany
Name of publisher, distributor, etc. Springer
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 194 pages
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents:<br/><br/>Introduction<br/><br/>Epidemiology Risk Factors and Survival in CUP Pointers to Disease Mechanisms<br/><br/>Biologic Features of CUP<br/><br/>Prognostic Factors and Their Role in the Management of CUP<br/><br/>Diagnostic Workup of CUP An Approach to Current Recommendations and Underlying Evidence<br/><br/>The Radiologists Approach to CUP<br/><br/>Cancer of Unknown Primary The Pathologists Approach<br/><br/>Treatment of Disseminated CUP<br/><br/>Concepts of Radiotherapy in Cancer of Unknown Primary<br/><br/>Favorable Subsets Among Cancers of Unknown Primary<br/><br/>Novel Diagnostic and Therapeutic Strategies in the Management of Patients with Cancers of Unknown Primary Site<br/><br/>Future Directions<br/><br/><br/>
520 ## - SUMMARY, ETC.
Summary, etc. This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and prognostic factors through to the most recent diagnostic and therapeutic advances. All aspects of management are covered, including radiological, nuclear medicine, and pathological diagnosis, site-specific therapies, platinum-based combination chemotherapy, radiotherapy, and novel targeted treatments. Clear guidance is offered on diagnosis of the tissue of origin by means of gene expression and micro-RNA analyses and its therapeutic implications. Detailed directions are also provided on the identification of subsets of patients with a more favorable prognosis, in whom specific treatment offers the chance of long-term survival or even cure. Readers will find Cancer of Unknown Primary to be an ideal source of practically oriented information that will assist in delivery of the best possible care for patients with this challenging diagnosis.
Expansion of summary note Common terms and phrases: adenocarcinoma analysis biopsy brain metastases breast cancer cancer classifier assays cancer of unknown cancer types carcinoma of unknown cervical CUP cervical lymph nodes chemotherapy cisplatin Clin Oncol clinical colorectal cancer CUP patients detection diagnostic disease evaluation favorable subset gemcitabine gene expression profiling genetic germ cell tumors Greco guidelines Hainsworth JD head and neck Hemminki histological identified IHC staining imaging immunohistochemical immunohistochemistry lesion Löffler lung cancer lymph node metastases lymphoma malignant markers median survival melanoma molecular cancer classifier molecular profiling months mutations neuroendocrine tumors nodal occult primary Oncology Pathol pathological patients with carcinoma patients with CUP Pavlidis Pentheroudakis performance status peritoneal poorly differentiated carcinoma primary cancer primary sites primary tumor prognostic factors Pubmed Central PubMed Epub PubMed PMID Radiat Oncol Biol radiotherapy renal cell carcinoma site-specific therapy specific Spigel DR squamous cell carcinoma subgroups targeted therapeutic tissue of origin treatment trials ultrasound unknown primary
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Pathology
9 (RLIN) 27023
General subdivision Medical / Oncology / General
9 (RLIN) 26891
General subdivision Medical / Diagnostic Imaging / General
9 (RLIN) 26867
General subdivision Medical / Clinical Medicine
9 (RLIN) 26816
General subdivision Medical / Allied Health Services / Imaging Technologies
9 (RLIN) 26763
General subdivision Medical › Oncology › General
9 (RLIN) 26780
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 38268
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   05/31/2022   616.99/4 EBS11242 05/31/2022 05/31/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024